Dopamine D2 receptor antagonism suppresses tau aggregation and neurotoxicity
about
The Role of Dopamine and Its Dysfunction as a Consequence of Oxidative StressUsing C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseasesNeurodegeneration and microtubule dynamics: death by a thousand cutsEthosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expressionCaenorhabditis elegans: a model to investigate oxidative stress and metal dyshomeostasis in Parkinson's diseaseInvited review: Prion-like transmission and spreading of tau pathology.Invited review: Animal models of tauopathies and their implications for research/translation into the clinic.Pharmacological approaches for Alzheimer's disease: neurotransmitter as drug targets.Unraveling protein misfolding diseases using model systemsDrug Discovery in Fish, Flies, and Worms.Worming our way to Alzheimer's disease drug discovery.Haloperidol inactivates AMPK and reduces tau phosphorylation in a tau mouse model of Alzheimer's diseaseDopa Decarboxylase Modulates Tau Toxicity.Risk neurogenes for long-term spaceflight: dopamine and serotonin brain system.Clozapine Modulates Glucosylceramide, Clears Aggregated Proteins, and Enhances ATG8/LC3 in Caenorhabditis elegans.Palmitoylation as a Functional Regulator of Neurotransmitter Receptors.α-Methyl-α-phenylsuccinimide ameliorates neurodegeneration in a C. elegans model of TDP-43 proteinopathy
P2860
Q26771824-B772B85E-DD4C-45C1-B39E-E4554DD1B77FQ26776093-193185BB-620E-412E-94A3-7A7AC958FFAAQ26781649-B0C29BCB-C89D-4D84-9216-72BA7771061AQ30666205-E60888ED-00B9-4CD0-BA4D-EBFF6F757CEEQ33658107-CB887C41-4871-49A1-B09C-B0E12B7AB427Q38268519-3CB2866D-00A3-47F9-BDB7-6BA8DBDA8C23Q38271896-2EA9FE0A-C7F1-44B6-8C92-E05CC744F29CQ38286222-A0434319-3024-4AB0-9F75-2BF9FABEA505Q38970045-3423649E-FADF-434A-B4E9-CD6D5C052246Q39039978-48BEEFAD-5F17-48D9-B276-5172C2139A90Q42144977-E523070F-8C84-43A1-BB27-F77D356C6CF3Q42689688-CB13BA85-0665-42D5-989B-0F567C27740DQ47659329-583E0177-ED7F-4125-968B-E1BFD826387FQ48624653-609CE60F-B17D-46EA-9702-864BC4F0FA6DQ50481966-6479823B-ED1C-4048-8AA1-FB13CB30E464Q55256658-6F3F6561-FFF8-42AB-A038-5D68FC1B31BFQ57143998-B791A53C-7366-415D-91E6-5FD5AF7BC9E9
P2860
Dopamine D2 receptor antagonism suppresses tau aggregation and neurotoxicity
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Dopamine D2 receptor antagonism suppresses tau aggregation and neurotoxicity
@ast
Dopamine D2 receptor antagonism suppresses tau aggregation and neurotoxicity
@en
type
label
Dopamine D2 receptor antagonism suppresses tau aggregation and neurotoxicity
@ast
Dopamine D2 receptor antagonism suppresses tau aggregation and neurotoxicity
@en
prefLabel
Dopamine D2 receptor antagonism suppresses tau aggregation and neurotoxicity
@ast
Dopamine D2 receptor antagonism suppresses tau aggregation and neurotoxicity
@en
P2093
P2860
P921
P1476
Dopamine D2 receptor antagonism suppresses tau aggregation and neurotoxicity
@en
P2093
Allyson V McCormick
Brian C Kraemer
Chris R Guthrie
P2860
P304
P356
10.1016/J.BIOPSYCH.2012.08.027
P407
P577
2012-11-07T00:00:00Z